Clinical Trial Update: Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy

View source ↗

Summary

Observational study assessing venetoclax-based regimens for relapsed or refractory chronic lymphocytic leukemia in Italy, outside traditional clinical trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Chronic Lymphocytic Leukemia, Relapse Leukemia | Status: RECRUITING